MOTIV BTK RCT: Safety & Effectiveness Study of the MOTIV Sirolimus-Eluting Bioresorbable Coronary Scaffold Compared with Plain Balloon Angioplasty for the Treatment of Infrapopliteal Lesions–Primary Safety Endpoint
Interventional Cardiology and Vascular Intervention Heart and Vascular Institute of the Rockies Interventional Cardiology Denver, Colorado, United States
.jpg "Ehrin Armstrong, MD photo")